Results 21 to 30 of about 417,620 (216)

Response to Shami et al. ‘Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong’ (Hum Vacc Immunother 2020)

open access: yesHuman Vaccines & Immunotherapeutics, 2021
The recently published article by Shami et al. describes a cost-effectiveness analysis of sequential pneumococcal vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23 ...
Ulrike K. Buchwald   +2 more
doaj   +1 more source

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study

open access: yesPLoS Medicine, 2020
Background Vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV23) is available in the United Kingdom to adults aged 65 years or older and those in defined clinical risk groups.
H. Lawrence   +14 more
semanticscholar   +1 more source

COMMUNITY-ACQUIRED PNEUMONIA PNEUMOCOCCAL ETIOLOGY AND MICROBIOLOGICAL ASPECTS OF NASOPHARYNGEAL CARRIAGE IN CHILDREN IN THE REPUBLIC OF TATARSTAN

open access: yes, 2017
Prevalence estimate of pneumococcus carrier in preschool age children (medically fragile children with respiratory diseases and practically healthy organized children) have been carried out; microbiological features of clinical isolates S.
L. Bayazitova   +8 more
semanticscholar   +1 more source

Impact of preceding flu-like illness on the serotype distribution of pneumococcal pneumonia.

open access: yesPLoS ONE, 2014
BackgroundEven though the pathogenicity and invasiveness of pneumococcus largely depend on capsular types, the impact of serotypes on post-viral pneumococcal pneumonia is unknown.Methods and findingsThis study was performed to evaluate the impact of ...
Joon Young Song   +3 more
doaj   +1 more source

Pneumococcal carriage and serotype distribution among children with and without pneumonia in Mozambique, 2014-2016.

open access: yesPLoS ONE, 2018
BackgroundPneumococcal colonization is a precursor to pneumonia, and pneumococcal conjugate vaccines (PCV) can decrease vaccine-type (VT) colonization.
Tolulope Adebanjo   +9 more
doaj   +1 more source

Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization.

open access: yesJournal of Clinical Investigation, 2020
Patients with respiratory syncytial virus (RSV) infection exhibit enhanced susceptibility to subsequent pneumococcal infections. However, the underlying mechanisms involved in this increased susceptibility remain unclear.
T. Shibata   +10 more
semanticscholar   +1 more source

A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population

open access: yesPathogens, 2020
Adult vaccination is high on the agenda in many countries. Two different vaccines are available for the prevention of pneumococcal disease in adults: a 23-valent polysaccharide vaccine (PPV23), and a 13-valent conjugated vaccine (PCV13). The objective of
Jacob Dag Berild   +6 more
semanticscholar   +1 more source

Impact of Pneumococcal Conjugate Vaccination of Infants on Pneumonia and Influenza Hospitalization and Mortality in All Age Groups in the United States

open access: yesmBio, 2011
A seven-valent pneumococcal conjugate vaccine (PCV7) introduced in the United States in 2000 has been shown to reduce invasive pneumococcal disease (IPD) in both vaccinated children and adults through induction of herd immunity. We assessed the impact of
Lone Simonsen   +5 more
doaj   +1 more source

Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.

open access: yesPLoS ONE, 2013
BackgroundPneumococcal pneumonia causes significant morbidity and mortality among adults. Given limitations of diagnostic tests for non-bacteremic pneumococcal pneumonia, most studies report the incidence of bacteremic or invasive pneumococcal disease ...
Maria A Said   +47 more
doaj   +1 more source

Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Since the early 2000s, pneumococcal conjugate vaccines (PCVs) have been shown to be effective in the prevention of pneumonia and invasive pneumococcal diseases.
I. Rivero-Calle   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy